newsfilter
← Latest News
GlobeNewswire·

Prevail Therapeutics to Webcast Conference Call of Second Quarter 2020 Financial Results

NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with...